Fibrosis-4 Score (FIB-4) screening in patients with diabetes mellitus by a retrospective analysis of HbA1c laboratory requisitions

• Conditions: E11; Type 2 diabetes mellitus

• Registration Number: DRKS00032154
• Lead Sponsor: niversität Leipzig, Bereich Hepatologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-06-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 750000

Inclusion Criteria

HbA1c values
ALT, AST, platelets
Age
Sex

Exclusion Criteria

none

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Estimation of the prevalence of the three FIB-4 risk categories in patients with HbA1c > 6.5% stratified by sex and age

Secondary Outcome Measures

Name	Time	Method
Comparison of patients with HbA1c > 6.5% vs. < 6.5% according to age and sex. <br>In patients with HbA1c > 6.5%, comparision between individuals with and without available FIB-4 score, stratified to sex and age.<br>Estimation of the relevance of the HbA1c value on the FIB-4 category stratified by age and sex.